Time flies with great content! Renew in to keep enjoying all our premium content.
Prime
World Bank gives Sh19bn for Kenya’s vaccine facility
Kenya BioVax Institute CEO Dr Michael Lusiola (left), World Bank Vice President for Human Development Mamta Murthi (centre) and State Department for Medical Services PS Harry Mutai when they toured Kenya BioVax Institute in Embakasi, Nairobi on February 7, 2024.
Photo credit: File | Evans Habil | Nation Media Group
The World Bank has committed $120 million (Sh19.1 billion at current exchange rates) to fund Kenya’s vaccine production facility, which is expected to start operations in 2029.
Health PS Harry Kimutai disclosed the funding when he accompanied the World Bank vice president for human development Mamta Murthi, on her tour of the facility in Embakasi in Nairobi, on Wednesday.
